SEC Form 4/A · accession 0000899243-17-004751
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owners
William F Doyle
Officer — Executive Chairman · Director · 10% Owner
WFD Ventures Fund II, L.P.
10% Owner
Period of report
Jan 3, 2017
Accepted (ET)
Feb 21, 2017 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2,F1 | holding | — | — | — | 18,923,393 | I | WFD Ventures Fund II, L.P. | |
| Ordinary SharesF2 | holding | — | — | — | 82,671 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.
- F2This Form 4/A amends the Form 4 filed on January 4, 2017 to accurately reflect the securities reported in Table I, Column 5, Rows 1 and 2. All other information contained in the original Form 4 was accurately reported.